Inspecs Group plc (SPEC) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.071x

Based on the latest financial reports, Inspecs Group plc (SPEC) has a cash flow conversion efficiency ratio of 0.071x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX6.29 Million ≈ $765.19 USD) by net assets (GBX89.10 Million ≈ $10.84K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SPEC net asset quality index to measure how much of total assets are equity-financed.

Inspecs Group plc - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Inspecs Group plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SPEC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Inspecs Group plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Inspecs Group plc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
FNP Technologies SA
PA:MLFNP
N/A
Prominence Energy Ltd
AU:PRM
-0.560x
Gafisa S.A
SA:GFSA3
-0.084x
Tracsis Plc
LSE:TRCS
0.106x
Fjordland Exploration Inc
V:FEX
2.832x
Pacific Imperial Mines Inc
V:PPM
0.021x
KOOL2PLAY S.A. ZY -10
F:8Q8
-0.070x
XTL Biopharmaceuticals Ltd
F:H2K2
N/A

Annual Cash Flow Conversion Efficiency for Inspecs Group plc (2016–2024)

The table below shows the annual cash flow conversion efficiency of Inspecs Group plc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see SPEC market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 GBX98.69 Million
≈ $12.01K
GBX7.20 Million
≈ $875.91
0.073x -40.38%
2023-12-31 GBX103.52 Million
≈ $12.60K
GBX12.66 Million
≈ $1.54K
0.122x +213.49%
2022-12-31 GBX130.09 Million
≈ $15.83K
GBX5.08 Million
≈ $617.72
0.039x -61.79%
2021-12-31 GBX145.22 Million
≈ $17.67K
GBX14.83 Million
≈ $1.80K
0.102x +2813.26%
2020-12-31 GBX145.82 Million
≈ $17.74K
GBX-548.86K
≈ $-66.78
-0.004x -101.11%
2019-12-31 GBX31.35 Million
≈ $3.81K
GBX10.59 Million
≈ $1.29K
0.338x +73.93%
2018-12-31 GBX22.71 Million
≈ $2.76K
GBX4.41 Million
≈ $536.93
0.194x -40.49%
2017-12-31 GBX19.55 Million
≈ $2.38K
GBX6.38 Million
≈ $776.55
0.326x -57.59%
2016-12-31 GBX2.23 Million
≈ $271.14
GBX1.72 Million
≈ $208.74
0.770x --

About Inspecs Group plc

LSE:SPEC UK Medical Instruments & Supplies
Market Cap
$1.20 Million
GBX9.86 Billion GBX
Market Cap Rank
#30450 Global
#777 in UK
Share Price
GBX97.00
Change (1 day)
+0.00%
52-Week Range
GBX39.50 - GBX100.50
All Time High
GBX405.33
About

INSPECS Group plc designs, produces, sells, markets, and distributes fashion eyewear, lenses, and OEM products in the United Kingdom, Europe, North America, South America, Asia, Africa, and Australia. It operates through Frames and Optics; Manufacturing; and Lenses segments. The company offers its products under the retail brands, such as Barbour, Barbour International, BUFFALO David Bitton, CAT,… Read more